| Literature DB >> 31411133 |
Amélie Desvars-Larrive1, Werner Ruppitsch2, Sarah Lepuschitz2, Michael P Szostak1, Joachim Spergser1, Andrea T Feßler3, Stefan Schwarz3, Stefan Monecke4,5,6, Ralf Ehricht4,6, Chris Walzer1,7, Igor Loncaric1.
Abstract
BackgroundBrown rats (Rattus norvegicus) are an important wildlife species in cities, where they live in close proximity to humans. However, few studies have investigated their role as reservoir of antimicrobial-resistant bacteria.AimWe intended to determine whether urban rats at two highly frequented sites in Vienna, Austria, carry extended-spectrum β-lactamase-producing Enterobacteriaceae, fluoroquinolone-resistant Enterobacteriaceae and meticillin-resistant (MR) Staphylococcus spp. (MRS).MethodsWe surveyed the presence of antimicrobial resistance in 62 urban brown rats captured in 2016 and 2017 in Vienna, Austria. Intestinal and nasopharyngeal samples were cultured on selective media. We characterised the isolates and their antimicrobial properties using microbiological and genetic methods including disk diffusion, microarray analysis, sequencing, and detection and characterisation of plasmids.ResultsEight multidrug-resistant Escherichia coli and two extensively drug-resistant New Delhi metallo-β-lactamases-1 (NDM-1)-producing Enterobacter xiangfangensis ST114 (En. cloacae complex) were isolated from nine of 62 rats. Nine Enterobacteriaceae isolates harboured the bla CTX-M gene and one carried a plasmid-encoded ampC gene (bla CMY-2). Forty-four MRS were isolated from 37 rats; they belonged to seven different staphylococcal species: S. fleurettii, S. sciuri, S. aureus, S. pseudintermedius, S. epidermidis, S. haemolyticus (all mecA-positive) and mecC-positive S. xylosus.ConclusionOur findings suggest that brown rats in cities are a potential source of multidrug-resistant bacteria, including carbapenem-resistant En. xiangfangensis ST114. Considering the increasing worldwide urbanisation, rodent control remains an important priority for health in modern cities.Entities:
Keywords: ESBL; Enterobacter xiangfangensis ST114; Escherichia coli; NDM-1; Rattus norvegicus; antimicrobial resistance; meticillin-resistant Staphylococcus
Mesh:
Substances:
Year: 2019 PMID: 31411133 PMCID: PMC6693289 DOI: 10.2807/1560-7917.ES.2019.24.32.1900149
Source DB: PubMed Journal: Euro Surveill ISSN: 1025-496X
Figure 1Workflow of the laboratory testing of urban brown rats for antimicrobial-resistant bacteria, Vienna, 13 September 2016–6 June 2017
Molecular characteristics of Enterobacteriaceae isolates from wild urban brown rats, Vienna, Austria, 13 September 2016–6 June 2017 (n = 10)
| Isolatea | Species | Resistance profile | Serogenotyping | Phylogroup | ST | Antimicrobial resistance genes | Virulence factors | CTX environment | Repli-con | Transconjugants | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| O-serotyping | H-serotyping | β-lactamase | Non-β-lactamase | Mutation in | Mutation in | IS | IS |
| ||||||||
| AD8E |
| AMP, CFZ, CTX, FQR | 21 | 21 | B1 | ST101 |
| NA | 83Ser-Leu, 87Asp-Asn | 80Ser-Ile |
| NA | NA | NA | NA | NA |
| AD10Ea |
| AMP, CFZ, CTX, FQR, TET, SXT | ND | 33 | C | ST34 |
|
| 83Ser-Val | Wild type |
| 1.7 | 0.25 | NA | NA | NA |
| AD10Eb |
| AMP, CFZ, CTX, TET, SXT | 86 | 18 | E | ST38 |
|
| Wild type | Wild type |
| NA | NA | NA | NA | NA |
| AD19E |
| AMP, CFZ, CTX | 6 | 49 | B1 | ST1079 |
| NA | NA | NA | NA | NA | 0.25 | NA | NA | NA |
| AD21E |
| AMP, CFZ, CTX | 6 | 49 | B1 | ST1079 |
| NA | NA | NA | NA | NA | 0.25 | F |
| |
| AD24E |
| AMP, CFZ, CTX, SXT | 8 | 25 | B1 | ST58 |
|
| NA | NA |
| NA | NA | NA | NA | NA |
| AD32E |
| AMP, CFZ, CTX, ATM, FQR, TET, CHL, SXT | 9 | 30 | C | ST361 |
|
| 83Ser-Leu, 87Asp-Asn | 80Ser-Ile |
| 2.5 | 0.25 | NA | FIB, F |
|
| AD54E |
| AMP, CFZ, CTX, FEP, IPM, MEM, ETP, ATM, FQR, GEN, TOB, TET, CHL, SXT | NA | NA | NA | ST114 |
|
| 83Ser-Leu | NA | NA | 2.5 | 0.25 | NA | H12 |
|
| AD72E |
| AMP, CFZ, CTX, FEP, IPM, MEM, ETP, ATM, FQR, GEN, TOB, TET, CHL, SXT | NA | NA | NA | ST114 |
|
| 83Ser-Leu | NA | NA | 2.5 | 0.25 | NA | H12 |
|
| AD74E |
| AMP, CFZ, CTX, ATM, FQR, TET, CHL, SXT | 8 | 30 | B1 | ST1431 |
|
| 83Ser-Leu, 87Asp-Asn | 80Ser-Ile |
| > 3 | 3 | NA | N |
|
AMP: ampicillin; ATM: aztreonam; CFZ: cefazolin; CHL: chloramphenicol; CTX: cefotaxime; ETP: ertapenem; FEP: cefepime; FQR: fluoroquinolone; GEN: gentamicin; IPM: imipenem; MEM: meropenem; NA: data not available; ND: not detected; ST: sequence type; SXT: trimethoprim-sulfamethoxazole; TET: tetracycline; TOB: tobramycin.
a Rat ID + E: Enterobacteriaceae isolate. When several isolates were identified, they were given a letter (a, b, etc).
Resistance and virulence genetic profile of Staphylococcus spp. isolates from wild urban brown rats, Vienna, Austria, 13 September 2016–6 June 2017 (n = 44)
| Isolatea | Speciesb | No. isolates |
| SCC | CC | Antimicrobial resistance profile | Virulence factors | |
|---|---|---|---|---|---|---|---|---|
| Phenotype | Genes detected | |||||||
| AD6 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD7 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD8 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD9 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD9b_MRSP |
| 1 | dt11av | V | NA | BLA, TET, ERY, CLI, AMK, GEN, FQR |
|
|
| AD10 |
| 1 | NA | Irregular | NA | BLA |
| NA |
| AD10b_S.xylosus_mecC |
| 1 | NA | XI | NA | BLA |
| NA |
| AD11 |
| 1 | NA | Irregular | NA | BLA |
| NA |
| AD13 |
| 1 | NA | Irregular | NA | BLA |
| NA |
| AD15 |
| 1 | NA | Irregular | NA | BLA |
| NA |
| AD16 |
| 3 | NA | Irregular | NA | BLA |
|
|
| AD16 |
| 1 | NA | Irregular | NA | BLA |
|
|
| AD17 |
| 3 | NA | Irregular | NA | BLA |
|
|
| AD19 |
| 2 | NA | Irregular | NA | BLA, ERY, TET |
| NA |
| AD23 |
| 3 | NA | Irregular | NA | BLA |
|
|
| AD24 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD25 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD27 |
| 1 | NA | Irregular | NA | BLA |
| NA |
| AD28 |
| 1 | NA | Irregular | NA | BLA |
| NA |
| AD30 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD31 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD32 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD33 |
| 1 | NA | Irregular | NA | BLA |
| NA |
| AD34 |
| 1 | NA | Irregular | NA | BLA |
|
|
| AD35 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD36 |
| 1 | NA | Irregular | NA | BLA |
| NA |
| AD37 |
| 1 | NA | Irregular | NA | BLA |
| NA |
| AD37 |
| 1 | NA | Irregular | NA | BLA |
|
|
| AD38 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD39 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD50 |
| 2 | NA | Irregular | NA | BLA, ERY, TET |
| NA |
| AD52 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD59 |
| 1 | NA | Irregular | NA | BLA |
|
|
| AD61 |
| 1 | NA | Irregular | NA | BLA |
|
|
| AD68_MRSE |
| 1 | dt10a | Pseudo SCC | NA | BLA, TET, ERY, CLI, AMK, GEN |
| NA |
| AD69a |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD69b |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD70 |
| 1 | NA | Irregular | NA | BLA |
|
|
| AD70_MRSA |
| 1 | dt11a | VT | CC398 | BLA, TET, ERY, CLI |
|
|
| AD71 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD72 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD74 |
| 19 | NA | Irregular | NA | BLA |
| NA |
| AD74_MRSH |
| 1 | NA | V | NA | BLA, TET, ERY, CLI, GEN |
|
|
| AD76 |
| 19 | NA | Irregular | NA | BLA |
| NA |
AMK: amikacin; BLA: β-lactams; CLI: clindamycin; ERY: erythromycin; FQR: fluoroquinolone; GEN: gentamicin; NA: data not available (absent, therefore not amplified, or not typeable); TET: tetracycline.
a Rat ID + isolate identification if several isolates were isolated from the same rat.
b Number in bracket refers to the isolate identification in Figure 2.
c SCCmec-typing via array was performed on these isolates.
Figure 2SCCmec type of selected MR Staphylococcus spp. isolates from wild urban brown rats, Vienna, Austria, 13 September 2016–6 June 2017 (n = 17)
Figure 3Relative frequencies of antimicrobial resistance phenotypes at each investigated site in (A) Enterobacteriaceae and (B) Staphylococcus spp. isolates, Vienna, Austria, 13 September 2016–6 June 2017 (n = 44)